News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Magic Mushroom Dreams
Jef Akst | Jul 3, 2014
A psychedelic compound in hallucinogenic mushrooms triggers brain activity characteristic of dream states.
Week in Review: April 14–18
Tracy Vence | Apr 18, 2014
Genome-wide effects of trisomy 21; RNA-based signs of transgenerational stress; depression and resilience; a call to overhaul US biomedical research system
Triggering Resilience to Depression
Ed Yong | Apr 17, 2014
In mice, boosting depression-causing activity in neurons can actually reverse depressive symptoms.
Depression Biomarker Found
Bob Grant | Feb 19, 2014
Researchers identify elevated levels of a stress hormone in teenage boys as a signpost of major depression.
Depression Speeds Aging
Bob Grant | Nov 12, 2013
Cells in the bodies of depressed people appear older and contain chromosomes with shorter telomeres.
Lozano on DBS
Andres Lozano | Nov 1, 2013
Neurosurgeon Andres Lozano discusses deep-brain stimulation in this TEDx talk.
Tuning the Brain
Andres Lozano | Oct 28, 2013
Deep-brain stimulation is allowing neurosurgeons to adjust the neural activity in specific brain regions to treat thousands of patients with myriad neurological disorders.
Ketamine Alternative Shows Promise
Abby Olena | Oct 17, 2013
Researchers show that lanicemine is an effective antidepressant without the adverse effects of the related hallucinogenic drug.
Clock Genes Linked to Depression
Edyta Zielinska | May 15, 2013
Patients with major depressive disorder appear to have malfunctioning circadian rhythms, which could lead researchers to new avenues for treatment.
Ketamine Encourages Nerve Remodeling
Jef Akst | Oct 16, 2012
The commonly abused hallucinogen shows promise in extinguishing fear in rats, pointing to possible benefits for patients with post-traumatic stress disorder.